Carrillo ER, Carrillo CJR, Carrillo CLD

Language: English
References: 9
Page: 144-145
PDF size: 124.75 Kb.

Text Extraction

69 years old woman without antecedents of hepatic disease who was admitted to Intensive Care Unit by severe pneumonia. Clinical exploration with nodular hepatomegaly without ascitis or splenomegaly. Liver function test with total proteins 7 g/dL, albumin 3.6 g/dL, Globulins 3.4 g/dL, total bilirrubins 0.62 mg/dL, Direct bilirrubin 0.15 mg/dL, Indirect bilirrubin 0.47 mg/dL, ALT 31 U/L, AST 40 U/L, AP 85 U/L, GGT 34U/L, LDH 188 U/L. Creatinine 0.8 mg/dL, BUN 13.3 mg/dL.

REFERENCES

1. D’Agata ID, Jonas MM, Perez-Atayde AR, Guay-Woodford LM. Combined cystic disease of the liver and kidney. Semin Liver Dis 1994; 14: 215-28.

2. Vauthey JN, Maddern GJ, Blumgart LH. Adult polycystic disease of the liver. Br J Surg 1991; 78: 524-7.

3. Levine E, Cook LT, Grantham JJ. Liver cysts in autosomal-dominant polycystic kidney disease: Clinical and computed tomographic study. Am J Roentgenol 1985; 145: 229-33.

4. Ramos A, Torres VE, Holley KE, Offord KP, Rakela J, Ludwig J. The liver in autosomal dominant polycystic kidney disease. Implications for pathogenesis. Arch Pathol Lab Med 1990; 114: 180-84.

5. Patterson M, Gonzalez-Vitale JC, Fagan CJ. Polycystic liver disease: A study of cyst fluid constituents. Hepatology 1982; 2: 475-8.

6. Alvaro D, Gigliozzi A, Attili AF. Regulation and deregulation of cholangiocyte proliferation. J Hepatol 2000; 33: 333-40.

7. Russell RT, Pinson CW. Surgical management of polycystic liver disease. World J Gastroenterol 2007; 13: 5052-9.

8. Li TJ, Zhang HB, Lu JH, Zhao J, Yang N, Yang GS. Treatment of polycystic liver disease with resection-fenestration and a new classification. World J Gastroenterol 2008; 14: 5066-72.

9. Van Keimpema L, de Man RA, Drenth JP. Somatostatin analogues reduce liver volume in polycystic liver disease. Gut 2008; 57:1338-9.